All In MedTech

Device type · JIT

Calibrator, Secondary

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about JIT: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

JIT

Clinical Chemistry

Device class

Class II

FDA decisions since 2015

15

510(k), De Novo and PMA

Adverse event reports

7

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Calibrator, Secondary
Product code
JIT
Device class
Class II
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1150

Latest FDA decisions

The 8 newest of 15 since 2015.

All decisions for JIT

12 more FDA decisions with a free account

Reports received

7

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

7

100% of reports

Injury reports

0

0.0% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 231000
Jan 240000
Feb 240000
Mar 242000
Apr 240000
May 240000
Jun 242000
Jul 240000
Aug 240000
Sep 246000
Oct 241000
Nov 246000
Dec 240000
Jan 253000
Feb 251000
Mar 250000
Apr 250000
May 250000
Jun 253000
Jul 250000
Aug 250000
Sep 250000
Oct 250000
Nov 250000
Dec 250000
Jan 260000
Feb 260000
Mar 260000
Apr 260000
May 260000
Jun 261000
Jul 260000
Aug 261000
Sep 262000
Oct 263000
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • High Test Results7
  • Low Test Results5

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions7

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Aniara Diagnostica LLC

    Z-2894-2026 · Started Jul 1, 2026 · Posted by FDA Aug 5, 2026

    Reason given: Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.

    Cause as FDA categorized it: Process control

  • Mckesson Medical-Surgical Inc. Corporate Office

    Z-1848-2025 · Started Apr 24, 2025 · Posted by FDA May 27, 2025

    Reason given: transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.

    Cause as FDA categorized it: Storage

  • Mckesson Medical-Surgical Inc. Corporate Office

    Z-1849-2025 · Started Apr 24, 2025 · Posted by FDA May 27, 2025

    Reason given: transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.

    Cause as FDA categorized it: Storage

52 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.